Institutional sellers dominated buyers in RHYTHM PHARMACEUTICALS, INC. at 1600 on 02/08/2024
Post date: 2024-02-09 04:23:24 GMT
This chart shows distribution of institutional flows for RYTM: % institutional buyers in green and % institutional sellers in red. The proportions of the institutional flows are estimated as a % of the total volume traded in RYTM at 1600 on 02/08/2024. As the chart shows, there is more mass on the sellers side of institutional flows than on the buyers side. However, the history of institutional flows and their relative proportion over time also matters.
Rhythm Pharmaceuticals, Inc. (RYTM) is a biopharmaceutical company that is dedicated to developing treatments for rare genetic disorders that are caused by obesity-related gene mutations. The company's mission is to improve the lives of patients with these disorders by providing innovative and effective therapies. Rhythm Pharmaceuticals is known for its unique approach to drug development, using deep understanding of the biology of metabolic disorders to identify potential targets and develop precision medicines. With a strong focus on research and development, along with a dedicated team of scientists and experts in the field, Rhythm Pharmaceuticals is poised to make a significant impact in the treatment of rare genetic disorders.
More Real-Time Research
